Councils - Pulmonary Hypertension



Scientific Council on Pulmonary Hypertension



NOT A COUNCIL MEMBER?

Council membership is open to all ISHLT members. Joining is easy. Simply login to the ISHLT Members Only Website where you can update your membership profile and join any of the 12 Scientific Councils.



CALL FOR COUNCIL VICE CHAIR NOMINATIONS

NOMINATION FORM


PAST COUNCIL MEETING:
Wednesday, April 5, 2017, 12:30 PM - 2:30 PM
in Grand Hall D of the Manchester Grand Hyatt Hotel, San Diego, CA, USA, during the ISHLT 37th Annual Meeting and Scientific Sessions



APPROVED CORE COMPETENCY CURRICULUM DOCUMENTS:

Pulmonary Hypertension (PDF)



MONOGRAPH VOLUME 9: Pulmonary Hypertension and Right Heart Failure is available to order.

Visit ishlt.org/publications/monographSeries for more information.



GRANT AWARD IN PH:

The ISHLT is pleased to announce the ISHLT/Bayer Pulmonary Hypertension Research Grant Award. Click HERE for details.



LINKS NEWSLETTER:

Issues focusing on Pulmonary Hypertension:

March 2017
November 2016
February 2016
October 2015
June 2015: PH Council Year in Review
January 2015
September 2014
March 2014
October 2013
May 2013: PH Council Year in Review
July 2012
December 2011 (PDF)



COUNCIL LEADERSHIP OPERATING BOARD
(Parentheses after name indicates year rotating off Board)


COUNCIL CHAIR:

Dana P. McGlothlin, MD (2020)
Kaiser San Francisco
San Francisco, California, USA

Dr. Dana McGlothlin obtained her undergraduate and medical degrees at the University of Kansas before heading west to the Mayo Clinic in Arizona, where she completed her internal medicine residency and cardiology fellowship. She then joined the faculty at the University of California San Francisco after completing an advanced fellowship in echocardiography in 2003. While at UCSF, she developed an interest and expertise in pulmonary hypertension, cardiac amyloidosis, advanced heart failure, heart transplantation, and mechanical assist devices, although she enjoy all aspects of cardiology care, including prevention and treatment of all of the more common cardiovascular diseases.



COUNCIL VICE CHAIR:

Jean-Luc Vachiery, MD (2022)
Erasme University Hospital - ULB
Brussels, Belgium

Jean-Luc Vachiéry is Clinical Professor of Cardiology and Director of the Pulmonary Vascular Diseases and heart Failure Clinic at the Hôpital Erasme – Cliniques Universitaires de Bruxelles, Belgium. He received his board certification in Internal Medicine in 1992 and in Cardiology in 1995. Robert Naeije has stimulated his interest in the right ventricle and pulmonary circulation in the late 1980’s. Since then, Jean-Luc Vachiery has authored several articles, book chapter and participated in many collaborative research projects. This led to the creation of a clinical unit dedicated to patient management and clinical research in pulmonary hypertension and heart failure in 2008. Jean-Luc has co-chaired the Pulmonary Hypertension Council at the International Heart and Lung Society (2002 – 2005), the Working Group on Pulmonary Circulation and Right Ventricular Function at the European Society of Cardiology (2006 – 2008) and the Working Group on Heart Failure at the Belgian Society of Cardiology (2008 – 2008). He was a Task Force member and section editor of the European Guidelines on pulmonary Hypertension (2009 and 2015).

Jean-Luc has also been involved in the World Symposium on Pulmonary Hypertension as task force member in 2003, (co-chair of the PH due to heart and lung diseases task force) 2013 and is currently the co-chair of the Task Force on Pulmonary Hypertension due to left heart diseases for the upcoming World Symposium on Pulmonary Hypertension in 2018. Jean-Luc acts as expert for several regulatory agencies and scientific organizations for matters related to medicines for pulmonary hypertension.




COUNCIL PAST CHAIR:

Mardi Gomberg-Maitland, MD, MSc (2018)
Inova Fairfax Hospital, Falls Church, VA, USA

Mardi Gomberg-Maitland, MD, MSc, is Associate Professor of Medicine and Director of the Pulmonary Hypertension Program at the University of Chicago Medical Center.  She is an expert clinician and researcher in the field of pulmonary heart disease. In recent years, she has participated in dozens of multi-center, multi-national research trials to explore new therapies for pulmonary hypertension. She is a former Doris Duke Clinical Scientist winner for her research in Phase I drug development. She is currently focusing on pulmonary arterial, pulmonary venous hypertension/diastolic dysfunction, and biomarker development. Dr. Gomberg-Maitland attended medical school at the Albert Einstein College of Medicine in New York. She completed her residency at the New York Presbyterian Hospital-Weill/Cornell Medical Center and a fellowship at Mount Sinai Medical Center in New York.  In addition, she has earned a Masters in Clinical Epidemiology from Harvard School of Public Health in Boston, Massachusetts. She is board certified in Internal Medicine and Cardiology.



BOARD OF DIRECTORS LIAISON:

Teresa De Marco, MD, FACC (2018)
University of California, San Francisco
San Francisco, California, USA

Teresa De Marco, MD, completed her internal medicine residency and cardiology fellowship at the University of California, San Francisco (UCSF). She completed training in heart transplantation at the University of Utah Medical Center in 1989 and since then has been on the faculty at UCSF. She is Board Certified in Internal Medicine, Cardiovascular Medicine and Advanced Heart Failure/Transplant Cardiology. She is currently Professor of Medicine and Surgery. She holds the R.H. and Jane G. Logan Endowed Chair in Cardiology. She is the Director of the Advanced Heart Failure Therapies Program and Medical Director of Heart Transplantation. She is Director of the Adult Pulmonary Hypertension Comprehensive Care Center. She serves as Director of the Advanced Heart Failure and Transplant Cardiology Fellowship Program.

She has authored or co-authored over 150 publications. Since 1989, Dr. De Marco has participated in over 30 clinical research trials. She has served on a multitude of national and international steering, events, and data monitoring committees for clinical research trials in heart failure, pulmonary hypertension and device therapies. She has chaired numerous scientific symposia, has lectured extensively at medical institutions, and has been a frequently invited international speaker. Dr. De Marco is a member of multiple societies including the International Society of Heart and Lung Transplantation (ISHLT). She has served as the Pulmonary Hypertension Council representative on the Standards and Guidelines Committee and on the ISHLT Program Committee. She served as the 2016 Chair of the ISHLT Academy Core Competencies Course in Heart Failure and Cardiac Transplant Medicine.





EDUCATION WORKFORCE LEADER:

Ioana R. Preston, MD (2018)
Tufts Medical Center
Boston, MA, USA

Dr. Ioana Preston obtained her medical degree at the Carol Davila University of Medicine and Pharmacy in Bucharest, Romania and trained in internal medicine (residency) and pulmonary and critical care medicine (fellowship) at Brown Medical School in Providence, RI and completed an advanced research pulmonary fellowship at Tufts Medical Center. She joined the faculty at Tufts Medical Center in Boston, MA in 2003.

Dr. Preston’s research interests include the role of inflammatory pathways in the pathogenesis of experimental and human pulmonary hypertension, as well as the contribution of the mineralocorticoid receptor pathway in this disease. She has been actively involved in numerous clinical trials leading to the approval of current therapies and has authored over 30 original peer reviewed papers on the topic of pulmonary hypertension.

Dr. Preston is actively involved in the leadership of the Pulmonary Hypertension Association. She is the director of the Pulmonary Hypertension Center at Tufts.




I2C2 WORKFORCE LEADER:

Manreet Kanwar, MD (2019)
Allegheny General Hospital
Pittsburgh, PA, USA

Manreet Kanwar, MD, completed her internal medicine residency and fellowship in cardiovascular diseases at St John Hospital and Medical Science in Detroit, MI. She then completed her advanced fellowship in heart failure, pulmonary hypertension and cardiac transplantation at Allegheny General Hospital, Pittsburgh in 2011 and joined the faculty thereafter. Dr. Kanwar was the chair of Junior Faculty Council at ISHLT for the year 2015-2016 . Her research interests include risk stratification in advanced heart failure and pulmonary hypertension. She is currently the associate director for the CTEPH program at AGH and an active member of both the PH and CTEPH council at ISHLT.



STANDARDS AND GUIDELINES COMMITTEE WORKFORCE LEADER:

Oksana Shlobin, MD (2020)
Inova Fairfax Hospital
Falls Church, VA, USA

Oksana A. Shlobin, MD, FCCP, is director of education for the Inova Advanced Lung Disease and Transplant Program at Inova Fairfax Hospital and co-director of the Inova Pulmonary Vascular Disease Program. She is also an associate professor of clinical medicine at Georgetown University School of Medicine and assistant clinical professor of medicine at Virginia Commonwealth University. Dr. Shlobin is board certified in pulmonary and critical care medicine. Dr. Shlobin has been actively involved in clinical research in PH, ILD and LTx both during her fellowship at Johns Hopkins and her tenure at Inova. She is co-author of multiple publications, including original research manuscripts, abstracts and book chapters. She has been actively involved at the ISHLT in Pulmonary Hypertension council. In 2016 and 2017, she served as the representative of the council on the Annual Meeting planning committee. She was appointed to the S&R committee for a 3 year term in 2017.



LINKS NEWSLETTER LIAISON:

Amresh Raina, MD
Allegheny General Hospital
Pittsburgh, PA, USA

Dr. Amresh Raina is the Associate Director of the Pulmonary Hypertension Program at Allegheny General Hospital in Pittsburgh, Pennsylvania and Assistant Professor of Medicine at Temple University School of Medicine. He is also on the echocardiography staff at Allegheny General Hospital.

Dr. Raina completed his undergraduate education at Harvard University and medical school and residency in Internal Medicine at Columbia University in New York. He then completed fellowship in cardiovascular disease as well as additional training in advanced heart failure and pulmonary hypertension at the University of Pennsylvania in Philadelphia.

His clinical and research interests have focused on right ventricular imaging, particularly as it pertains to pulmonary arterial hypertension as well as risk stratification in PAH. He has authors over 40 peer reviewed manuscripts and book chapters, as well as countless abstracts. He has served as the communications liason for the Pulmonary Hypertension Council of the ISHLT since 2014. 




LIAISONS TO OTHER COUNCILS:

BSTR COUNCIL LIAISON:

Aaron B Waxman, MD, PhD
Brigham & Women's Hospital
Boston, MA, USA

Bio coming soon...





JFTC LIAISON:

Marco A. Caccamo, DO
West Virginia University
Morgantown, WV, USA

Marco Caccamo, DO, is currently an Associate Professor of Medicine at West Virginia School of Medicine and medical director of the pulmonary hypertension program. He completed his residency training at the Cleveland Clinic in 2009. Dr. Caccamo then moved to Minneapolis, Minnesota where he completed his cardiology training at the University of Minnesota in 2012. He then completed an additional year in advanced heart failure and pulmonary hypertension at Allegheny General Hospital in Pittsburgh, PA. His clinical interests include pulmonary hypertension, mechanical circulatory support and cardiac transplantation.



NHSAH COUNCIL LIAISON:

Rachel M Crackett, MSc
Freeman Hospital
Newcastle Upon Tyne, UNITED KINGDOM

Rachel Crackett RGN, MSc, NP has been a  Nurse Specialist in the Northern Pulmonary Vascular Unit at Freeman Hospital in Newcastle for over 14 years.  She has worked within the cardiothoracic department at Freeman for over 20 years with experience in surgery, medicine, transplantation and research. During this time she completed a Master’s degree in Nursing Science (Research Methods) and the Nursing Practitioner RCN Award. She has been integral in the development of the pulmonary hypertension service both locally and nationally and currently represents the northern senate with the National Commissioning Reference Group which advises on national policy. Rachel has presented and had abstracts accepted at local, national and international meetings.



COUNCIL LEADERSHIP OPERATING BOARD
(Parentheses after name indicates year rotating off Board)


COUNCIL CHAIR:

Dana P. McGlothlin, MD (2020)
Kaiser San Francisco
San Francisco, California, USA

Dr. Dana McGlothlin obtained her undergraduate and medical degrees at the University of Kansas before heading west to the Mayo Clinic in Arizona, where she completed her internal medicine residency and cardiology fellowship. She then joined the faculty at the University of California San Francisco after completing an advanced fellowship in echocardiography in 2003. While at UCSF, she developed an interest and expertise in pulmonary hypertension, cardiac amyloidosis, advanced heart failure, heart transplantation, and mechanical assist devices, although she enjoy all aspects of cardiology care, including prevention and treatment of all of the more common cardiovascular diseases.


COUNCIL VICE CHAIR:

Jean-Luc Vachiery, MD (2022)
Erasme University Hospital - ULB
Brussels, Belgium

Jean-Luc Vachiéry is Clinical Professor of Cardiology and Director of the Pulmonary Vascular Diseases and heart Failure Clinic at the Hôpital Erasme – Cliniques Universitaires de Bruxelles, Belgium. He received his board certification in Internal Medicine in 1992 and in Cardiology in 1995. Robert Naeije has stimulated his interest in the right ventricle and pulmonary circulation in the late 1980’s. Since then, Jean-Luc Vachiery has authored several articles, book chapter and participated in many collaborative research projects. This led to the creation of a clinical unit dedicated to patient management and clinical research in pulmonary hypertension and heart failure in 2008. Jean-Luc has co-chaired the Pulmonary Hypertension Council at the International Heart and Lung Society (2002 – 2005), the Working Group on Pulmonary Circulation and Right Ventricular Function at the European Society of Cardiology (2006 – 2008) and the Working Group on Heart Failure at the Belgian Society of Cardiology (2008 – 2008). He was a Task Force member and section editor of the European Guidelines on pulmonary Hypertension (2009 and 2015).

Jean-Luc has also been involved in the World Symposium on Pulmonary Hypertension as task force member in 2003, (co-chair of the PH due to heart and lung diseases task force) 2013 and is currently the co-chair of the Task Force on Pulmonary Hypertension due to left heart diseases for the upcoming World Symposium on Pulmonary Hypertension in 2018. Jean-Luc acts as expert for several regulatory agencies and scientific organizations for matters related to medicines for pulmonary hypertension.



COUNCIL PAST CHAIR:

Mardi Gomberg-Maitland, MD, MSc (2018)
Inova Fairfax Hospital, Falls Church, VA, USA

Mardi Gomberg-Maitland, MD, MSc, is Associate Professor of Medicine and Director of the Pulmonary Hypertension Program at the University of Chicago Medical Center.  She is an expert clinician and researcher in the field of pulmonary heart disease. In recent years, she has participated in dozens of multi-center, multi-national research trials to explore new therapies for pulmonary hypertension. She is a former Doris Duke Clinical Scientist winner for her research in Phase I drug development. She is currently focusing on pulmonary arterial, pulmonary venous hypertension/diastolic dysfunction, and biomarker development. Dr. Gomberg-Maitland attended medical school at the Albert Einstein College of Medicine in New York. She completed her residency at the New York Presbyterian Hospital-Weill/Cornell Medical Center and a fellowship at Mount Sinai Medical Center in New York.  In addition, she has earned a Masters in Clinical Epidemiology from Harvard School of Public Health in Boston, Massachusetts. She is board certified in Internal Medicine and Cardiology.


BOARD OF DIRECTORS LIAISON:

Teresa De Marco, MD, FACC (2018)
University of California, San Francisco
San Francisco, California, USA

Teresa De Marco, MD, completed her internal medicine residency and cardiology fellowship at the University of California, San Francisco (UCSF). She completed training in heart transplantation at the University of Utah Medical Center in 1989 and since then has been on the faculty at UCSF. She is Board Certified in Internal Medicine, Cardiovascular Medicine and Advanced Heart Failure/Transplant Cardiology. She is currently Professor of Medicine and Surgery. She holds the R.H. and Jane G. Logan Endowed Chair in Cardiology. She is the Director of the Advanced Heart Failure Therapies Program and Medical Director of Heart Transplantation. She is Director of the Adult Pulmonary Hypertension Comprehensive Care Center. She serves as Director of the Advanced Heart Failure and Transplant Cardiology Fellowship Program.

She has authored or co-authored over 150 publications. Since 1989, Dr. De Marco has participated in over 30 clinical research trials. She has served on a multitude of national and international steering, events, and data monitoring committees for clinical research trials in heart failure, pulmonary hypertension and device therapies. She has chaired numerous scientific symposia, has lectured extensively at medical institutions, and has been a frequently invited international speaker. Dr. De Marco is a member of multiple societies including the International Society of Heart and Lung Transplantation (ISHLT). She has served as the Pulmonary Hypertension Council representative on the Standards and Guidelines Committee and on the ISHLT Program Committee. She served as the 2016 Chair of the ISHLT Academy Core Competencies Course in Heart Failure and Cardiac Transplant Medicine.



EDUCATION WORKFORCE LEADER:

Ioana R. Preston, MD (2018)
Tufts Medical Center
Boston, MA, USA

Dr. Ioana Preston obtained her medical degree at the Carol Davila University of Medicine and Pharmacy in Bucharest, Romania and trained in internal medicine (residency) and pulmonary and critical care medicine (fellowship) at Brown Medical School in Providence, RI and completed an advanced research pulmonary fellowship at Tufts Medical Center. She joined the faculty at Tufts Medical Center in Boston, MA in 2003.

Dr. Preston’s research interests include the role of inflammatory pathways in the pathogenesis of experimental and human pulmonary hypertension, as well as the contribution of the mineralocorticoid receptor pathway in this disease. She has been actively involved in numerous clinical trials leading to the approval of current therapies and has authored over 30 original peer reviewed papers on the topic of pulmonary hypertension.

Dr. Preston is actively involved in the leadership of the Pulmonary Hypertension Association. She is the director of the Pulmonary Hypertension Center at Tufts.



I2C2 WORKFORCE LEADER:

Manreet Kanwar, MD (2019)
Allegheny General Hospital
Pittsburgh, PA, USA

Manreet Kanwar, MD, completed her internal medicine residency and fellowship in cardiovascular diseases at St John Hospital and Medical Science in Detroit, MI. She then completed her advanced fellowship in heart failure, pulmonary hypertension and cardiac transplantation at Allegheny General Hospital, Pittsburgh in 2011 and joined the faculty thereafter. Dr. Kanwar was the chair of Junior Faculty Council at ISHLT for the year 2015-2016 . Her research interests include risk stratification in advanced heart failure and pulmonary hypertension. She is currently the associate director for the CTEPH program at AGH and an active member of both the PH and CTEPH council at ISHLT.


STANDARDS AND GUIDELINES COMMITTEE WORKFORCE LEADER:

Oksana Shlobin, MD (2020)
Inova Fairfax Hospital
Falls Church, VA, USA

Oksana A. Shlobin, MD, FCCP, is director of education for the Inova Advanced Lung Disease and Transplant Program at Inova Fairfax Hospital and co-director of the Inova Pulmonary Vascular Disease Program. She is also an associate professor of clinical medicine at Georgetown University School of Medicine and assistant clinical professor of medicine at Virginia Commonwealth University. Dr. Shlobin is board certified in pulmonary and critical care medicine. Dr. Shlobin has been actively involved in clinical research in PH, ILD and LTx both during her fellowship at Johns Hopkins and her tenure at Inova. She is co-author of multiple publications, including original research manuscripts, abstracts and book chapters. She has been actively involved at the ISHLT in Pulmonary Hypertension council. In 2016 and 2017, she served as the representative of the council on the Annual Meeting planning committee. She was appointed to the S&R committee for a 3 year term in 2017.


LINKS NEWSLETTER LIAISON:

Amresh Raina, MD
Allegheny General Hospital
Pittsburgh, PA, USA

Dr. Amresh Raina is the Associate Director of the Pulmonary Hypertension Program at Allegheny General Hospital in Pittsburgh, Pennsylvania and Assistant Professor of Medicine at Temple University School of Medicine. He is also on the echocardiography staff at Allegheny General Hospital.

Dr. Raina completed his undergraduate education at Harvard University and medical school and residency in Internal Medicine at Columbia University in New York. He then completed fellowship in cardiovascular disease as well as additional training in advanced heart failure and pulmonary hypertension at the University of Pennsylvania in Philadelphia.

His clinical and research interests have focused on right ventricular imaging, particularly as it pertains to pulmonary arterial hypertension as well as risk stratification in PAH. He has authors over 40 peer reviewed manuscripts and book chapters, as well as countless abstracts. He has served as the communications liason for the Pulmonary Hypertension Council of the ISHLT since 2014. 



LIAISONS TO OTHER COUNCILS:

BSTR COUNCIL LIAISON:

Aaron B Waxman, MD, PhD
Brigham & Women's Hospital
Boston, MA, USA

Bio coming soon...

JFTC LIAISON:

Marco A. Caccamo, DO
West Virginia University
Morgantown, WV, USA

Marco Caccamo, DO, is currently an Associate Professor of Medicine at West Virginia School of Medicine and medical director of the pulmonary hypertension program. He completed his residency training at the Cleveland Clinic in 2009. Dr. Caccamo then moved to Minneapolis, Minnesota where he completed his cardiology training at the University of Minnesota in 2012. He then completed an additional year in advanced heart failure and pulmonary hypertension at Allegheny General Hospital in Pittsburgh, PA. His clinical interests include pulmonary hypertension, mechanical circulatory support and cardiac transplantation.


NHSAH COUNCIL LIAISON:

Rachel M Crackett, MSc
Freeman Hospital
Newcastle Upon Tyne, UNITED KINGDOM

Rachel Crackett RGN, MSc, NP has been a  Nurse Specialist in the Northern Pulmonary Vascular Unit at Freeman Hospital in Newcastle for over 14 years.  She has worked within the cardiothoracic department at Freeman for over 20 years with experience in surgery, medicine, transplantation and research. During this time she completed a Master’s degree in Nursing Science (Research Methods) and the Nursing Practitioner RCN Award. She has been integral in the development of the pulmonary hypertension service both locally and nationally and currently represents the northern senate with the National Commissioning Reference Group which advises on national policy. Rachel has presented and had abstracts accepted at local, national and international meetings.

Text SizeIncrease Font SizeDecrease Font Size